A detailed history of Hilltop Holdings Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Hilltop Holdings Inc. holds 7,978 shares of NVO stock, worth $688,182. This represents 0.06% of its overall portfolio holdings.

Number of Shares
7,978
Previous 3,924 103.31%
Holding current value
$688,182
Previous $560,000 69.46%
% of portfolio
0.06%
Previous 0.07%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $482,709 - $589,532
4,054 Added 103.31%
7,978 $949,000
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $192,654 - $230,648
1,570 Added 66.69%
3,924 $560,000
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $240,366 - $319,955
2,354 New
2,354 $302,000
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $741,448 - $896,268
-7,964 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $45,926 - $56,081
479 Added 6.4%
7,964 $892,000
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $41,619 - $52,563
493 Added 7.05%
7,485 $718,000
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $201,017 - $251,821
2,971 Added 73.89%
6,992 $586,000
Q1 2021

May 17, 2021

BUY
$67.06 - $75.82 $269,648 - $304,872
4,021 New
4,021 $271,000
Q4 2020

Feb 16, 2021

SELL
$63.89 - $73.8 $276,388 - $319,258
-4,326 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$63.69 - $70.22 $1,210 - $1,334
-19 Reduced 0.44%
4,326 $300,000
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $254,356 - $295,199
4,345 New
4,345 $284,000
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $219,256 - $287,169
-4,433 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $62,723 - $73,291
-1,258 Reduced 22.11%
4,433 $256,000
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $16,448 - $18,486
346 Added 6.47%
5,691 $294,000
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $52,498 - $58,871
-1,122 Reduced 17.35%
5,345 $273,000
Q1 2019

May 15, 2019

SELL
$46.36 - $52.63 $48,028 - $54,524
-1,036 Reduced 13.81%
6,467 $339,000
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $15,203 - $17,293
-366 Reduced 4.65%
7,503 $346,000
Q3 2018

Nov 14, 2018

SELL
$46.76 - $51.24 $16,880 - $18,497
-361 Reduced 4.39%
7,869 $371,000
Q2 2018

Aug 14, 2018

SELL
$44.29 - $50.42 $23,340 - $26,571
-527 Reduced 6.02%
8,230 $380,000
Q1 2018

May 15, 2018

SELL
$48.49 - $58.14 $18,523 - $22,209
-382 Reduced 4.18%
8,757 $431,000
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $71,247 - $80,541
1,499 Added 19.62%
9,139 $491,000
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $314,386 - $376,040
7,640
7,640 $368,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $195B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hilltop Holdings Inc. Portfolio

Follow Hilltop Holdings Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hilltop Holdings Inc. with notifications on news.